Related Articles
Impact of radiation therapy on survival in patients with triple‑negative breast cancer
Evaluation of the benefit of post‑mastectomy radiotherapy in patients with early‑stage breast cancer: A propensity score matching study
Efficacy of post‑mastectomy radiotherapy in patients with T1‑2N1 breast cancer aged ≤35 years or with a positive HER‑2 status
No association between triple‑negative breast cancer and prognosis of patients receiving breast‑conserving treatment
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity Corrigendum in /10.3892/ijo.2021.5210